| RS368105987 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, FBN2-related disorder |
| RS368106957 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS368108311 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS368108883 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Inborn genetic diseases |
| RS368109068 |
TYK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 35, Inborn genetic diseases |
| RS368109121 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS368109133 |
CUL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS368110732 |
RSPH4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 11 |
| RS368111672 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS368112491 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rare genetic deafness, Familial cancer of breast |
| RS368113790 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS368113811 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial hypobetalipoproteinemia 1 |
| RS368113841 |
DNHD1
|
Health Risk |
Pathogenic |
— |
| RS368114257 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368114420 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS368114895 |
PSTPIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome, Pyogenic arthritis-pyoderma gangrenosum-acne syndrome |
| RS368115694 |
NADSYN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vertebral, cardiac |
| RS368115734 |
FGF23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypophosphatemic rickets, Tumoral calcinosis |
| RS368116362 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS368116696 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS368116715 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Familial thoracic aortic aneurysm and aortic dissection |
| RS368117488 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS368118099 |
PEX26
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS368118378 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS368119340 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
BENTA disease, Severe combined immunodeficiency due to CARD11 deficiency |
| RS368119524 |
TRIOBP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368119540 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS368120713 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS368121196 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS368121231 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS368121566 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Cardiomyopathy |
| RS368122191 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Holoprosencephaly 9 |
| RS368122233 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS368122278 |
CEP63
|
Health Risk |
Pathogenic |
— |
| RS368122382 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS368122868 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS368123079 |
PAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368123972 |
MPDU1
|
Health Risk |
Likely pathogenic |
— |
| RS368124046 |
OCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, SKIN/HAIR/EYE PIGMENTATION 1 |
| RS368124198 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS368124508 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 4A, MYH14-related disorder |
| RS368124753 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS368124813 |
VPS33B
|
Health Risk |
Pathogenic |
VPS33B-related disorder, Arthrogryposis |
| RS368124997 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Inborn genetic diseases |
| RS368125656 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, MYH9-related disorder |
| RS368126466 |
CYP27B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets, type 1 |
| RS368126549 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS368126732 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS368128494 |
EZH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Weaver syndrome, Intellectual disability |
| RS368129012 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, AMT-related disorder |
| RS368129741 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS368130496 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS368130981 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Inborn genetic diseases |
| RS368131175 |
PHKA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXa1, Inborn genetic diseases |
| RS368132097 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS368132822 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS368132877 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS368133957 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS368133994 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS368134008 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Inborn genetic diseases |
| RS368134308 |
PRKN
|
Health Risk |
Pathogenic |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS368134354 |
SPINK5
|
Health Risk |
Pathogenic/Likely pathogenic |
Increased circulating IgE concentration, Erythroderma |
| RS368135271 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368135633 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Donnai-Barrow syndrome |
| RS368136864 |
PRPF31
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS368136871 |
NCF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS368137511 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS368137679 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS368137821 |
CNGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS368138001 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Renal-hepatic-pancreatic dysplasia 1 |
| RS368138282 |
GLRA2
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Intellectual developmental disorder |
| RS368138379 |
HSPA1L
|
Health Risk |
association |
Inflammatory bowel disease 1, Inflammatory bowel disease 1 |
| RS368138514 |
FAT4
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT4-related disorder, Van Maldergem syndrome 2 |
| RS368139168 |
SPEN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS368139423 |
NDUFB10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368140002 |
PRDM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 8, Inborn genetic diseases |
| RS368141054 |
ARHGEF18
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS368142107 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS368142947 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368143665 |
GRID2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 18, Autosomal recessive spinocerebellar ataxia 18 |
| RS368144567 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS368144654 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS368146879 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS368146962 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS368147403 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked distal spinal muscular atrophy type 3, Menkes kinky-hair syndrome |
| RS368147684 |
CCDC78
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy with internal nuclei and atypical cores, Inborn genetic diseases |
| RS368148074 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS368148362 |
DNAJC21
|
Health Risk |
Likely pathogenic |
Inherited bone marrow failure syndrome, Bone marrow failure syndrome 3 |
| RS368148692 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS368149035 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS368149365 |
MPZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS368149368 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS368150158 |
SLC13A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 25 |
| RS368150737 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS368150818 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS368150874 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS368150943 |
CLPB
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylglutaconic aciduria, type VIIB |
| RS368151146 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Myopathy |
| RS368151192 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS368151220 |
WAS
|
Health Risk |
Pathogenic |
— |